Risk assessment of carcinogenic and noncarcinogenic chemicals.

"Risk Assessment" is a general term used with increasing frequency by both scientists and regulators. Scientifically based risk assessments consider available toxicologic data when judging which agents pose a significant risk to the human population. The science of toxicology focuses on identifying potential hazards to human health using surrogate animal studies. Margins of Safety and establishment of ADIs (Acceptable Daily Intakes) are methods applied to animal test data to set "safe" levels of potential exposure. While the use of Safety Factors in development of the ADI can support a pragmatic conclusion of safety, this approach cannot provide estimates of the probability of harm or the degree of safety. Therefore, Quantitative Risk Assessment (QRA) methods using mathematical models have been advanced to extrapolate from animal exposures which are usually high to much lower human exposure levels where experimental response is absent. Such methodology has been applied primarily by U.S. regulatory agencies to experimental oncogenic responses to estimate the risks of chemical exposure. The present manuscript considers both methods for evaluation of chemical safety and focuses on the scientific merits and limitations of each.

[1]  P. Armitage,et al.  Multistage models of carcinogenesis. , 1985, Environmental health perspectives.

[2]  A. Heusner Energy metabolism and body size. I. Is the 0.75 mass exponent of Kleiber's equation a statistical artifact? , 1982, Respiration physiology.

[3]  Gio Batta Gori Regulation of cancer-causing substances: Utopia or reality , 1982 .

[4]  H. Druckrey Quantitative Aspects in Chemical Carcinogenesis , 1967 .

[5]  2-acetylaminofluorene and the Weibull model. , 1981, Food and cosmetics toxicology.

[6]  W. Gary Flamm,et al.  Role of mathematical models in assessment of risk and in attempts to define management strategy , 1984 .

[7]  D. Clayson ICPEMC publication no. 13 the need for biological risk assessment in reaching decisions about carcinogens (MTR07214) , 1987 .

[8]  H. Stokinger Toxicology and Drinking Water Contaminants , 1977 .

[9]  T. Starr,et al.  Experimental design constraints on carcinogenic potency estimates. , 1989, Journal of toxicology and environmental health.

[10]  I W Davidson,et al.  Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.

[11]  F. Lu,et al.  Safety assessments of chemicals with thresholded effects. , 1985, Regulatory toxicology and pharmacology : RTP.

[12]  S. Moolgavkar Biologically motivated two-stage model for cancer risk assessment. , 1988, Toxicology letters.

[13]  V. Covello The perception of technological risks: A literature review , 1983 .

[14]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[15]  S. Moolgavkar,et al.  Biologically based models for cancer risk assessment: a cautionary note. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[17]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[18]  Harold Francis Blum,et al.  Carcinogenesis by Ultraviolet Light , 1959 .

[19]  W. Wieser,et al.  A distinction must be made between the ontogeny and the phylogeny of metabolism in order to understand the mass exponent of energy metabolism. , 1984, Respiration physiology.

[20]  J. Wahrendorf,et al.  Some examples of dose-response studies in chemical carcinogenesis. , 1976, Oncology.

[21]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[22]  K S Crump Models for carcinogenic risk assessment. , 1978, Science.

[23]  J. Cotruvo Drinking water standards and risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.

[24]  R. McCauley,et al.  The effect of in vivo exposure to diesel exhaust on rat hepatic and pulmonary microsomal activities , 1981, Journal of applied toxicology : JAT.

[25]  S. A. Richter,et al.  Cancer risk management A review of 132 federal regulatory decisions. , 1987, Environmental science & technology.

[26]  D. Hoel Statistical measures of risk. , 1982, Drug metabolism reviews.

[27]  D Hattis,et al.  Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  F. Vocci,et al.  Extrapolation of animal toxicity data to man. , 1988, Regulatory toxicology and pharmacology : RTP.

[29]  Quantitative Risk Assessment: State-of-the-Art for Carcinogenesis , 1983 .

[30]  J H Weisburger,et al.  Carcinogen testing: current problems and new approaches. , 1981, Science.

[31]  S. Salley,et al.  Ultrastructure and morphometry of the alveolar lung of guinea pigs chronically exposed to diesel engine exhaust: Six month's experience , 1981, Journal of applied toxicology : JAT.

[32]  James G. Wilson Environment and birth defects , 1973 .

[33]  S M Brett,et al.  Significant risk decisions in federal regulatory agencies. , 1987, Regulatory toxicology and pharmacology : RTP.

[34]  R. Wilson Measuring and comparing risks to establish a de minimis risk level. , 1988, Regulatory toxicology and pharmacology : RTP.

[35]  H. Jones,et al.  Analysis of mathematical models used in data extrapolation. , 1976, Clinical toxicology.

[36]  K S Crump,et al.  Correlation between carcinogenic potency of chemicals in animals and humans. , 1988, Risk Analysis.

[37]  Edward J. Calabrese,et al.  Principles of animal extrapolation , 1983 .

[38]  D J Paustenbach,et al.  A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. , 1988, Toxicology letters.

[39]  Risk estimation for environmental chemicals as a basis for decision making. , 1984, Regulatory toxicology and pharmacology : RTP.

[40]  O. G. Fitzhugh,et al.  100-Fold margin of safety , 1954 .

[41]  S. Moolgavkar,et al.  Two-event models for carcinogenesis: incidence curves for childhood and adult tumors☆ , 1979 .

[42]  E. Bingham,et al.  Environmental carcinogens. The modifying effect of cocarcinogens on the threshold response. , 1969, Archives of environmental health.

[43]  C. Brown Statistical aspects of extrapolation of dichotomous dose-response data. , 1978, Journal of the National Cancer Institute.

[44]  E A Crouch,et al.  Uncertainties in interspecies extrapolations of carcinogenicity. , 1983, Environmental health perspectives.

[45]  P. Watanabe,et al.  RISK ASSESSMENT OF ENVIRONMENTAL CARCINOGENS UTILIZING PHARMACOKINETIC PARAMETERS , 1979 .

[46]  J. Mordenti Dosage regimen design for pharmaceutical studies conducted in animals. , 1986, Journal of pharmaceutical sciences.

[47]  B. P. Mcnamara,et al.  Concepts in health evaluation of commercial and industrial chemicals , 1975 .

[48]  M E Andersen,et al.  Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. , 1988, The Journal of pharmacology and experimental therapeutics.

[49]  Elizabeth L. Anderson,et al.  Quantitative Approaches in Use to Assess Cancer Risk , 1983 .

[50]  K. Crump,et al.  Improved confidence limits for low-dose carcinogenic risk assessment from animal data☆ , 1985 .

[51]  E M Johnson,et al.  Cross-species extrapolations and the biologic basis for safety factor determinations in developmental toxicology. , 1988, Regulatory toxicology and pharmacology : RTP.

[52]  H. Guess,et al.  Low-dose-rate extrapolation of data from animal carcinogenicity experiments— analysis of a new statistical technique , 1976 .

[53]  R. Albert,et al.  Considerations relating to the formulation of limits for unavoidable population exposures to environmental carcinogens , 1972 .

[54]  J. Tukey,et al.  An improved Mantel-Bryan procedure for "safety" testing of carcinogens. , 1975, Cancer research.

[55]  O E Paynter,et al.  Goitrogens and thyroid follicular cell neoplasia: evidence for a threshold process. , 1988, Regulatory toxicology and pharmacology : RTP.

[56]  C. R. Cothern,et al.  Estimating risk for carcinogenic environmental contaminants and its impact on regulatory decision making. , 1984, Regulatory toxicology and pharmacology : RTP.

[57]  E J Calabrese,et al.  Uncertainty factors and interindividual variation. , 1985, Regulatory toxicology and pharmacology : RTP.

[58]  E. Anderson,et al.  New Risk Assessment Initiatives in Epa , 1985, Toxicology and industrial health.

[59]  D G Hoel,et al.  Fundamental carcinogenic processes and their implications for low dose risk assessment. , 1976, Cancer research.

[60]  P. Armitage,et al.  A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer , 1957, British Journal of Cancer.

[61]  Mantel Nathan,et al.  Safety" testing of carcinogenic agents. , 1961 .

[62]  D. J. Campbell Drug residues in animal tissues and their regulatory significance--the Canadian point of view. , 1978, Journal - Association of Official Analytical Chemists.

[63]  R. Zielhuis,et al.  The use of a safety factor in setting health based permissible levels for occupational exposure , 1979, International archives of occupational and environmental health.

[64]  J. Cornfield,et al.  Carcinogenic risk assessment. , 1977, Science.

[65]  P. Slovic Perception of risk. , 1987, Science.

[66]  J Van Ryzin,et al.  A generalized multihit dose-response model for low-dose extrapolation. , 1981, Biometrics.

[67]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[68]  G. Vettorazzi,et al.  SAFETY FACTORS AND THEIR APPLICATION IN THE TOXICOLOGICAL EVALUATION , 1977 .

[69]  D Krewski,et al.  Determining "safe" levels of exposure: safety factors or mathematical models? , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[70]  B. Butterworth,et al.  Nongenotoxic carcinogens in the regulatory environment. , 1989, Regulatory toxicology and pharmacology : RTP.

[71]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[72]  R. Tardiff,et al.  Review of interspecies risk comparisons. , 1988, Regulatory toxicology and pharmacology : RTP.

[73]  D Krewski,et al.  A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. , 1983, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[74]  Michael R. Taylor,et al.  Application of risk assessment to food safety decision making. , 1983, Regulatory toxicology and pharmacology : RTP.

[75]  F. A. Denz,et al.  Experimental methods used in determining chronic toxicity; a critical review. , 1954, Pharmacological reviews.

[76]  D G Hoel,et al.  Implication of nonlinear kinetics on risk estimation in carcinogenesis. , 1983, Science.

[77]  E J Bigwood,et al.  The acceptable daily intake of food additives. , 1973, CRC critical reviews in toxicology.

[78]  H. Feldman,et al.  The 3/4 mass exponent for energy metabolism is not a statistical artifact. , 1983, Respiration physiology.

[79]  K T Bogen,et al.  Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene. , 1988, Regulatory toxicology and pharmacology : RTP.

[80]  I C Munro,et al.  Risk assessment and regulatory decision making. , 1981, Food and cosmetics toxicology.

[81]  D. Krewski,et al.  Carcinogenic risk assessment: a guide to the literature. , 1981, Biometrics.

[82]  D G Hoel,et al.  Estimation of risks of irreversible, delayed toxicity. , 1975, Journal of toxicology and environmental health.

[83]  Gaylor Dw,et al.  Linear interpolation algorithm for low dose risk assessment of toxic substances. , 1980 .

[84]  Pike Mc,et al.  A method of analysis of a certain class of experiments in carcinogenesis. , 1966 .

[85]  Some practical problems arising from use of the gamma multihit model for risk estimation. , 1981, Journal of toxicology and environmental health.

[86]  L. Ellwein,et al.  Cell growth dynamics in long-term bladder carcinogenesis. , 1988, Toxicology letters.

[87]  D. Cox Regression Models and Life-Tables , 1972 .

[88]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[89]  M E Andersen,et al.  Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. , 1988, Toxicology letters.

[90]  R. Albert,et al.  Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. , 1977, Journal of the National Cancer Institute.

[91]  D. Pinkel The use of body surface area as a criterion of drug dosage in cancer chemotherapy. , 1958, Cancer research.

[92]  J. Wahrendorf,et al.  A dose‐response study on urethane carcinogenesis in rats and mice , 1977, International journal of cancer.

[93]  R. Albert,et al.  Approaches to the formulation of standards for carcinogenic substances in the environment. , 1979, Environmental health perspectives.

[94]  International commission for protection against environmental mutageus and carcinogeus: The need for biological risk assessment in reaching decisions about carcinogens , 1987 .

[95]  C. I. Bliss THE CALCULATION OF THE DOSAGE-MORTALITY CURVE , 1935 .

[96]  E. O'flaherty A physiologically based model of skeletal growth in the rat. , 1988, Toxicology letters.

[97]  David G. Hoel,et al.  Some Tautologous Aspects of the Comparison of Carcinogenic Potency in Rats and Mice , 1985 .

[98]  F C Lu Toxicological evaluations of carcinogens and noncarcinogens: pros and cons of different approaches. , 1983, Regulatory toxicology and pharmacology : RTP.

[99]  G. Williams,et al.  Carcinogen risk assessment. , 1983, Science.

[100]  W J Hayes,et al.  Toxicity of pesticides to man: risks from present levels , 1967, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[101]  B. Cohen,et al.  A catalog of risks. , 1979, Health physics.

[102]  F. Lu,et al.  Acceptable daily intake: inception, evolution, and application. , 1988, Regulatory toxicology and pharmacology : RTP.

[103]  Gross Ma,et al.  Evaluation of safety for food additives: An illustration involving the influence of methyl salicylate on rat reproduction. , 1970 .

[104]  D G Hoel,et al.  A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. , 1980, Toxicology and applied pharmacology.

[105]  W. S. Abbott,et al.  A method of computing the effectiveness of an insecticide. 1925. , 1925, Journal of the American Mosquito Control Association.

[106]  R L Sielken,et al.  Estimation of "safe doses" in carcinogenic experiments. , 1977, Journal of environmental pathology and toxicology.

[107]  T. D. Day Carcinogenic action of cigarette smoke condensate on mouse skin. , 1967, British Journal of Cancer.

[108]  C. S. Weil,et al.  Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .

[109]  R. Lutz,et al.  Implications of pharmacokinetic modeling in risk assessment analysis. , 1987, Environmental health perspectives.

[110]  H. Guess,et al.  Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data. , 1977, Cancer research.

[111]  G. Blau,et al.  Mechanisms of carcinogenesis: dose response. , 1978, Journal of environmental pathology and toxicology.

[112]  L. Fishbein,et al.  Overview of some aspects of quantitative risk assessment. , 1980, Journal of toxicology and environmental health.

[113]  F. W. Carlborg Dose-response functions in carcinogenesis and the Weibull model. , 1981, Food and cosmetics toxicology.

[114]  R. Zeckhauser,et al.  The perils of prudence: how conservative risk assessments distort regulation. , 1988, Regulatory toxicology and pharmacology : RTP.

[115]  Crump Ks,et al.  Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data. , 1977 .

[116]  P. Lee,et al.  Weibull distributions for continuous-carcinogenesis experiments. , 1973, Biometrics.

[117]  J. Young,et al.  Pharmacokinetics of inhaled styrene in rats and humans. , 1978, Scandinavian journal of work, environment & health.

[118]  M. Hogan Extrapolation of animal carcinogenicity data: limitations and pitfalls. , 1983, Environmental health perspectives.

[119]  B. L. Oser,et al.  Much ado about safety , 1969 .

[120]  V. Frankos FDA perspectives on the use of teratology data for human risk assessment , 1985 .

[121]  D B Menzel,et al.  Planning and using PB-PK models: an integrated inhalation and distribution model for nickel. , 1988, Toxicology letters.

[122]  P N Lee,et al.  Statistical Analysis of the Bio-assay of Continuous Carcinogens , 1972, British Journal of Cancer.

[123]  Philip L. Altman,et al.  Growth: including reproduction and morphological development. , 1962 .

[124]  P. Watanabe,et al.  Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. , 1978, Toxicology and applied pharmacology.

[125]  M. Cranmer Estimation of risks due to environmental carcinogenesis. , 1977, Medical and pediatric oncology.

[126]  M. Meistrich Estimation of human reproductive risk from animal studies: determination of interspecies extrapolation factors for steroid hormone effects on the male. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[127]  C C Travis,et al.  Interspecific scaling of toxicity data. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[128]  J. Young,et al.  Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.

[129]  G. Charnley,et al.  Biologically motivated cancer risk models. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.

[130]  A. Whittemore,et al.  Lung cancer incidence in cigarette smokers: further analysis of Doll and Hill's data for British physicians. , 1976, Biometrics.

[131]  Edmund A. C. Crouch,et al.  Interspecies comparison of carcinogenic potency , 1979 .

[132]  C S Weil,et al.  Statistics vs safety factors and scientific judgment in the evaluation of safety for man. , 1972, Toxicology and applied pharmacology.

[133]  Knut Schmidt-Nielsen,et al.  How Animals Work , 1972 .

[134]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[135]  D. Rall,et al.  Difficulties in extrapolating the results of toxicity studies in laboratory animals to man. , 1969, Environmental research.

[136]  L S Birnbaum,et al.  Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species. , 1983, Toxicology and applied pharmacology.

[137]  R. Truhaut An overview of the problem of thresholds for chemical carcinogens. , 1979, IARC scientific publications.